Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 536

Cerevance clears $45m series B

GV and Takeda have backed a series B round that will fund the Rockefeller University spinout's identification of targets for brain disease treatments.

Apr 15, 2020

Cerevance clears $45m series B

GV and returning investor Takeda Ventures chipped into a series B round that will fund the identification of targets for brain disease treatments.

Apr 15, 2020

SilverCloud sizzles with $16m series B

MemorialCare Innovation Fund led a series B round featuring UnityPoint Health Ventures and OSF Ventures, taking SilverCloud's total funding past $30m.

Apr 15, 2020

Corigin Ventures corrals $36m for second fund

Corigin's property and consumer technology-focused venture capital arm has closed its second fund and hired Aubrie Pagano in a partner position.

Apr 15, 2020

Daily deal net: April 14, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Apr 14, 2020

Bugcrowd bags $30m in series D round

The Salesforce-backed, crowd-focused cybersecurity services provider has now raised $80m altogether, VC firm Rally Ventures leading its latest round.

Apr 14, 2020

Daily deal net: April 9, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Apr 9, 2020

CVC in the Time of Coronavirus: Jason Miles, VFS Innovation Ventures

Although newly formed, Volvo Financial Services' strategic investment arm is optimstic about the potential of mature technologies meeting more inviting valuations.

Apr 9, 2020

Cohesity collects $250m in series E round

HPE, Cisco Investments and SoftBank Vision Fund chipped in as the data management platform developer more than doubled its valuation to $2.5bn.

Apr 9, 2020

Keros bosses IPO to raise $96m

Partners Healthcare and Medison Pharma-backed Keros Therapeutics floated at the top of its range and will look to advance its musculoskeletal disorder drug candidates.

Apr 9, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here